MedPath

Pulmonary Nodule Detection: Comparison of an Ultra Low Dose vs Standard Scan.

Not Applicable
Completed
Conditions
Lung Cancer
Smoking
Radiation Exposure
Interventions
Device: Low dose chest CT
Device: Ultra low dose chest CT
Registration Number
NCT03305978
Lead Sponsor
University Hospital, Grenoble
Brief Summary

Lung cancer screening programs are still discussed in Europe today, and one of the concern is radiation due to iterative CT. The aim of this monocentric, prospective, non randomized study is to compare an ultra low dose chest CT (approaching a two views X ray) versus a standard low dose chest CT for ≥4mm lung nodules detection, and secondary for lung nodule characterization and smoking associated findings (emphysema, bronchial abnormalities and coronary calcifications).

Detailed Description

An additional Ultra Low Dose CT, approaching 0.2mSv, will be performed in consenting patients referred for non enhanced chest CT in our Revolution CT scanner (GE Healthcare®).The dose delivered with the two acquisitions is still lower than the french diagnostic reference level. Standard CT is interpreted and a report is sent to the referent physician as usual. Then the two acquisitions are read over time by two independent radiologists, blinded over judgment criterias. In case of discordance, an other radiologist will arbitrate. We hope to validate our Ultra low dose chest CT protocol, which is more than 10 times less radiating than a standard low dose CT, as a sensitive tool to detect lung nodules.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Low dose chest CTLow dose chest CT-
Ultra low dose chest CTUltra low dose chest CT-
Primary Outcome Measures
NameTimeMethod
Ultra low dose CT lung nodule detection sensibility22 months

Detection rate (%) of ≥4mm lung nodules in ultra low dose chest CT versus standard low dose chest CT

Secondary Outcome Measures
NameTimeMethod
Concordance of bronchial abnormalities evaluation between ultra low dose and standard low dose chest CT22 months

comparison of detection of bronchial thickening or dilatation between ultra low dose and standard low dose chest CT

Ultra low dose CT diagnostic performances of lung nodule detection22 months

true positives, false positives, true negatives, false negatives, positive predictive value, negative predictive value, specificity, of ≥4mm lung nodules detection within ultra low dose chest CT versus standard low dose chest CT

Ultra low dose CT inter-observer reproducibility22 months

inter observer reproducibility for size, density and type of ≥4mm lung nodule detected in ultra low dose CT

Influence of subjects characteristics, nodule location, and nodule size on detection between ultra low dose and standard low dose chest CT22 months

analysis of subjects characteristics (age, gender, body mass index), ≥4mm nodule location, and ≥4 mm nodule size on detection between ultra low dose and standard low dose chest CT

Concordance of emphysema characteristics between ultra low dose and standard low dose chest CT22 months

comparison of emphysema detection, type (centrilobular, paraseptal, panlobular, bullous) and distribution between ultra low dose and standard low dose chest CT

Concordance of ≥4mm lung nodules characteristics between ultra low dose and standard low dose chest CT22 months

comparison of size, density, type (true nodule or intrapulmonary ganglion) of ≥4mm lung nodule between ultra low dose and standard low dose chest CT

Concordance of coronary calcification detection and quantification between ultra low dose and standard low dose chest CT22 months

Comparison of Weston scores between ultra low dose and standard low dose chest CT

Trial Locations

Locations (1)

University Hospital Grenoble

🇫🇷

Grenoble, France

© Copyright 2025. All Rights Reserved by MedPath